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Inflammasomes are multi-protein platforms that drive the activation of caspase-1 leading
to the processing and secretion of biologically active IL-1β and IL-18. Different inflamma-
somes including NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3), NLR
caspase-recruitment domain-containing 4 (NLRC4) and absent in melanoma 2 (AIM2)
are activated and assembled in response to distinct microbial or endogenous stimuli.
However, the mechanisms by which upstream stimuli trigger inflammasome activa-
tion remain poorly understood. Double-stranded RNA-activated protein kinase (PKR), a
protein kinase activated by viral infection, has been recently shown to be required for the
activation of the inflammasomes. Using macrophages from two different mouse strains
deficient in PKR, we found that PKR is important for the induction of the inducible nitric
oxide synthase (iNOS). However, PKR was dispensable for caspase-1 activation, process-
ing of pro-IL-1β/IL-18 and secretion of IL-1β induced by stimuli that trigger the activation
of NLRP3, NLRC4 and AIM2. These results indicate that PKR is not required for inflamma-
some activation in macrophages.
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Introduction
PKR, known as double-stranded RNA-activated protein kinase, is
activated by viral infection and plays an important role in con-
trolling viral spreading within the host [1, 2]. PKR contains an
N-terminal dsRNA binding domain and a C-terminal kinase
domain [3]. After activation by binding to viral dsRNA, PKR phos-
phorylates the translation initiation factor EIF2A to inhibit cellular
RNA translation leading to the inhibition of viral protein synthesis
[1]. PKR can also modulate NF-κB signaling and cellular apoptosis
[4,5]. In addition, stimulation of TLR4 can trigger PKR-mediated
apoptosis of macrophages, which allow some pathogens such as
Bacillus anthracis to escape immune clearance [6]. PKR can also
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link pathogen sensing to stress responses in metabolic disease [7].
Notably, PKR has been recently implicated in the processing of
caspase-1 and IL-1β secretion in response to diverse stimuli [8],
suggesting that this kinase acts in a common step required for
inflammasome activation.
Inflammasomes are intracellular multi-protein complexes that
drive the activation of the protease caspase-1 [9,10]. To date, four
bona fide inflammasomes have been identified, NOD-like receptor
(NLR) family pyrin domain-containing 1 (NLRP1), NLRP3, NLR
caspase-recruitment domain-containing 4 (NLRC4) and absent in
melanoma 2 (AIM2), that link specific microbial or endogenous
stimuli to caspase-1 activation [9, 10]. Once activated, caspase-1
proteolytically cleaves pro-IL1β and pro-IL-18 into their biolog-
ically active cytokines [11]. Although there is clear evidence
that the activation mechanism of each inflammasome is differ-
ent [9–11], a recent study reported that PKR is required for the
activation of NLRP3, NLRC4 and AIM2 [8]. The latter study sug-
gested that PKR is a common regulator of the inflammasomes.
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Figure 1. PKR is critical for LPS-induced iNOS production in
macrophages. (A) BMDMs from heterozygous (Pkr+/−) and homozy-
gous (Pkr−/−) mice were stimulated with 100 ng/mL LPS for indicated
time. Cell extracts were immunoblotted with antibodies reacting with
phosphorylated forms of IκBα, p38 or ERK. The immunoblots were
stripped and re-probed for total IκBα, p38 or ERK. Probing for PKR pro-
tein confirmed the genotype of Pkr−/−. (B) BMDMs were stimulated with
100 ng/mL LPS for indicated time. Cell lysates were immublotted for
iNOS and PKR. β-actin was used as a loading control. (C) BMDMs were
stimulated with 100 ng/mL of LPS for indicated time. Cell lysates were
immunoblotted for STAT1 and p-STAT1 (Tyr701). β-actin was used as a
loading control. (D) Live intracellular bacteria from BMDMs after indi-
cated time of infection with E. coli. Data shown are from one experiment
representative of three independent experiments. *p < 0.05, Student’s
t-test.
To further understand the role of PKR in caspase-1 activation,
we studied the activation of the NLRP3, NLRC4 and AIM2 in
macrophages from mice deficient in PKR. In contrast to published
results [8], we found that PKR is dispensable for inflammasome
activation.
Results and discussion
PKR is critical for LPS-induced iNOS production
in macrophages
PKR is phosphorylated in macrophages after LPS stimulation
[6,12]. To determine the potential role of PKR in the TLR4 signal-
ing pathway, we treated BM-derived macrophages (BMDMs) from
Pkr+/− and Pkr−/− mice with LPS for different times, and analysed
the phosphorylation status of IκBα, ERK and p38 (Fig. 1A). The
phosphorylation levels of these proteins was indistinguishable in
LPS-stimulated Pkr+/− and Pkr−/− macrophages, suggesting that
PKR protein is not required for NF-κB, ERK and p38 activation
in response to LPS. Notably, the production of iNOS, an enzyme
catalysing NO which is involved in host defense against microbes
[13], was markedly reduced in Pkr−/− macrophages when com-
pared with that of Pkr+/− macrophages (Fig. 1B). Several tran-
scription factors, including NF-κB, AP-1 and STAT1, have been
shown to regulate iNOS expression [13]. LPS-induced phospho-
rylation of STAT1 at Tyr 701, a site essential for its activation,
was not altered by PKR deficiency, indicating that it is unlikely
that PKR is involved in the upstream signaling pathway of STAT1
activation (Fig. 1C). Consistent with the reduction of iNOS expres-
sion, the bacteria-killing capacity after exposure to Escherichia
coli was reduced in Pkr−/− macrophages (Fig. 1D). Our results
confirm and extend previous findings that PKR plays a role in
LPS-induced iNOS production and bacteria-killing function of
macrophages.
PKR is dispensable for inflammasome activation
in macrophages
Next, we investigated the involvement of PKR in inflammasome
activation. LPS-primed Pkr+/− and Pkr−/− macrophages were
treated with known activators of NLRP3, NLRC4 and AIM2. In
contrast to a recent report [8], the amounts of processed caspase-1
(p20 and p10), and IL-1β/IL-18 maturation in the cell supernatant
in response to activators of NLRP3 including ATP, nigerin and
silica particles were comparable in Pkr+/− and Pkr−/−
macrophages (Fig. 2A). No role for PKR was also found in the
activation of caspase-1 and pro-IL-1β/IL-18 processing after infec-
tion of macrophages with Salmonella thyphimurium that activates
the NLRC4 inflammasome (Fig. 2B). Furthermore, caspase-1 acti-
vation and IL-1β processing induced by poly (dA:dT) that trig-
gers AIM2 activation [14–16], was comparable in Pkr+/− and
Pkr+/− macrophages (Fig. 2C). ELISA analysis showed robust
IL-1β release in Pkr−/− macrophages after stimulation with ATP,
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Figure 2. PKR-deficient BMDMs show normal inflammasome acti-
vation. (A) BMDMs were un-stimulated (UT), or primed with LPS
(100 ng/mL) for 4 h before stimulated with NLRP3 activators, ATP (5 mM)
for 30 min, Nigericin (5 μM) for 1 h, Silica (500 μg/mL) for 6 h. (B) BMDMs
were primed with LPS (100 ng/mL) for 4 h, followed by infection with
Salmonella typhimurium (S. typhi., MOI = 10) for 1 h, or left uninfected. (C)
LPS-primed BMDMs were stimulated with 2 μg/mL poly (dA:dT) for 6 h
or left unstimulated. After stimulation or infection, supernatant (Sup.)
and cell lysates (Lys.) were prepared and immunoblotted for indicated
proteins. (D, E) The secretion of (D) IL-1β and (E) TNF-α from BMDMs
was analysed after inflammasome activation. Data are shown as the
mean ± SD of triplicate wells and all data shown are representative of
three independent experiments.
Salmonella and poly (dA:dT), although the amounts were slightly
reduced in Pkr−/− macrophages when compared with those in
Pkr+/− macrophages (Fig. 2D). However, similar reduction was
observed in TNF-α secretion (Fig. 2E), suggesting that the slight
reduction in IL-1β secretion in Pkr−/− macrophages is not related
to inflammasome activation.
Our initial studies were performed with PKR-deficient mice in
which the N-terminal RNA binding domain of PKR was deleted
[17]. In contrast, Lu et al. studied PKR using KO mice with dele-
tion of the catalytic domain of PKR [18]. Although both KO mice
lack expression of full-length PKR, some conflicting results have
been reported for these two mouse mutant strains [19]. There-
fore, we also studied inflammasome activation in macrophages
from mutant mice with deletion of the catalytic domain of PKR.
Analysis of macrophages from this Pkr−/− mouse strain also
revealed comparable caspase-1 activation and pro-IL-1β/IL-18
processing in response to activators of the NLRP3 inflamma-
some when compared with that of WT macrophages (Fig. 3A).
As expected, caspase-1 activation and pro-IL-1β/IL-18 procession
were abrogated in macrophages from Nlrp3−/− mice (Fig. 3A).
Likewise, caspase-1 activation and pro-IL-1β maturation induced
by aluminum salts (Alum), another activator of NLRP3, were
unimpaired in Pkr−/− macrophages, but abolished in Nlrp3−/−
macrophages (Fig. 3B). 2-aminopurin (2-AP), a potent inhibitor
of PKR, was reported to inhibit ATP-induced NLRP3 inflamma-
some activation at millimolar concentration [8]. Notably, addi-
tion of 2-AP at this high concentration inhibited ATP-induced
NLRP3 inflammasome activation in both WT and PKR-deficient
macrophages (Fig. 3C). This result suggests at this high concen-
tration, 2-AP inhibits the inflammasome through off-target effects.
Furthermore, caspase-1 activation in response to Salmonella or
poly (dA:dT) were unaffected by deletion of the catalytic domain
of PKR (Fig. 3D and E). Consistent with these results, IL-1β and
TNF-α release induced by ATP, Salmonella and poly (dA:dT) were
unimpaired in Pkr−/− macrophages (Fig. 3F and G).
Concluding remarks
Our results indicate that the protein kinase PKR plays a critical
role in regulating iNOS production by macrophages after LPS chal-
lenge, which correlated with reduced intracellular killing of E. coli.
However, we found no detectable role for PKR in the activation
of the NLRP3, NLRC4 or AIM2 inflammasomes in macrophages.
We do not have a clear explanation for the difference in results
between our studies and those of Lu et al. [8]. It is possible
that subtle variation in experimental conditions may account, at
least in part, for the differences in results. In our studies, parallel
experiments were performed using macrophages from mice defi-
cient in NLRP3 and NLRC4 that showed requirement for these
inflammasomes, but not PKR, for caspase-1 activation triggered
by specific stimuli. In addition, our conclusions regarding PKR
were obtained from experiments using two independently gener-
ated PKR-deficient mice that targeted two critical regions of PKR.




WT and Nlrp3-deficient mice have been described previously [20].
Two different types of PKR targeted mutations have been reported
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
1150 Yuan He et al. Eur. J. Immunol. 2013. 43: 1147–1152
Figure 3. Inflammasome activation was analysed in BMDMs with a targeted deletion of the catalytic domain of PKR. (A, B) BMDMs from WT mice,
Pkr−/− mice and Nlrp3−/− mice were primed with LPS (500 ng/mL) for 4 h before being stimulated with (A) NLRP3 activators, ATP (5 mM) for 30
min, Nigericin (5 μM) for 1 h, Silica (U.S. Silica, 500 μg/mL) or (B) Alum (500 μg/mL) for 6 h. (C) LPS-primed BMDMs from WT mice and Pkr−/−
mice were pre-treated with 1 mM 2-aminopurin (2-AP) or PBS (control) for 30 min before stimulation with 5 mM ATP for 30 min. (D) LPS-primed
BMDMs were infected with Salmonella typhimurium (S. typhi., MOI = 10) for 1 h, or uninfected. Caspase-1 cleavage was analysed by immunoblotting.
(E) LPS-primed BMDMs were stimulated with 2 μg/mL poly (dA:dT) for 6 h or left unstimulated. After stimulation, supernatant (Sup.) and cell
lysates (Lys.) were prepared and immunoblotted for indicated proteins. (F, G) The secretion of (F) IL-1β and (G) TNF-α from BMDMs was measured
after inflammasome activation. Data are shown as the mean + SD of triplicate wells and all data shown are representative of three independent
experiments.
in mice, targeted deletion of the PKR RNA-binding domain and
targeted deletion of PKR catalytic domain [17, 18]. Leg bones of
Pkr+/− and Pkr−/− mice with targeted deletion of the RNA-binding
domain of PKR, which were originally generated from on a mixed
129 SvEv x C57Bl6 background and backcrossed to C57BL/6 one
time [21], were a gift of Randal Kaufman (Sanford-Burham Med-
ical Research Institute, La Jolla). Leg bones of Pkr−/− mice with
targeted deletion of the catalytic domain of PKR were generated on
a 129Sv background and backcrossed to BALB/c mice at least six
times (a gift of Yingjie Chen, University of Minnesota, Minneapo-
lis). BMDMs were prepared and cultured as previously described
[22]. Cells were seeded overnight in 12-well plate with 1 × 106
cells per well.
Reagents
Ultrapure LPS from E. coli 0111:B4, Alum, 2-aminopurin (2-AP)
and poly(dA:dT)/lyovec were purchased from Invivogen. ATP was
purchased from Sigma. Nigericin was purchased from Calbiochem.
Salmonella enterica serovar typhimurium strain SL1344 was a gift
from Denise Monack (Stanford University, Stanford, CA). Anti-
bodies for IκBα, p-IκBα, p38, p-p38, Erk, p-Erk, iNOS, STAT1 and
p-STAT1 (Tyr 701) were purchased from Cell Signaling. Murine
IL-1β antibody (AF-401-NA) was purchased from R&D Systems.
Actin antibody was purchased from GenScript. Antibodies for PKR
(sc-6282) and caspase-1 (sc-514) were purchased from Santa
Cruz. Caspase-1 antibody for the cleaved p20 of caspase-1 was
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generated in our laboratory. IL-18 antibody (5180R-100) was
purchased from BioVision. Rabbit anti-mouse-Nlrp3 antibody
was generated by immunizing rabbits with mouse Nlrp3 protein
(amino acids 1–194) expressed in E. coli and purified by affinity
chromatography using a nickel column.
Bacteria-killing assay
BMDMs were incubated with E. coli strain at MOI of 10 for 30 min.
Extracellular bacteria were killed by treatment with gentamicin
(100 μg/mL) for 15 min. At indicated time points, cells were
lysed with 0.1% Trinton X-100 and serial dilutions of cell extract
were spread on LB agar plates. Live intracellular bacteria were
counted after overnight incubation in 37◦C.
Immunoblotting
Cells were lysed in ice-cold PBS buffer containing 1% NP-40
supplemented with complete protease inhibitor cocktail (Roche,
Mannheim, Germany). The proteins from cell-free supernatants
were precipitated by choloform/methanol method as previously
described [23]. Protein samples were separated by SDS-PAGE and
transferred to PVDF membranes by electroblotting (Bio-Rad) and
membranes were immunoblotted with respective antibodies.
Measurements of cytokines
Mouse IL-1β and TNF-α in culture supernatants were measured by
ELISA kits (R&D Systems). Assays were performed in triplicate for
each independent experiment.
Statistical analysis
Student’s t-test was used to determine statistically significant dif-
ference between two groups. A p-value of <0.05 was considered
significant.
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